Triple
T5873391
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Committee for Advanced Therapies |
E130569
|
entity |
| Predicate | typeOfAdvancedTherapiesAssessed |
P67339
|
FINISHED |
| Object | gene therapy medicinal products |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: gene therapy medicinal products | Statement: [Committee for Advanced Therapies, typeOfAdvancedTherapiesAssessed, gene therapy medicinal products]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: typeOfAdvancedTherapiesAssessed Context triple: [Committee for Advanced Therapies, typeOfAdvancedTherapiesAssessed, gene therapy medicinal products]
-
A.
potentialTherapeuticUse
Indicates that something is being considered or investigated as a possible treatment or therapy for a condition or disease.
-
B.
hasTherapeuticGoal
Indicates that an action, treatment, or intervention is undertaken with the intention of achieving a specific therapeutic or health-related outcome.
-
C.
subsequentTreatment
Indicates that one treatment occurs after and in response to a prior treatment or medical event.
-
D.
hasSubsequentTreatment
Indicates that one treatment occurs after and in continuation of another treatment in a temporal sequence.
-
E.
hasCommonTreatment
Indicates that two or more entities share at least one treatment method or therapeutic approach in common.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085047dc8190af24e311edad3c07 |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c0432fea5881909f5c291dd8db6105 |
completed | March 22, 2026, 7:29 p.m. |
| PD | Predicate disambiguation | batch_69c033499ca08190bd26cee5b03f6306 |
completed | March 22, 2026, 6:22 p.m. |
| PDg | Predicate description generation | batch_69c0432f06fc8190bc047d52ffc30d59 |
completed | March 22, 2026, 7:29 p.m. |
Created at: March 22, 2026, 3:57 p.m.